Cross Competitors
| CCRN Stock | USD 8.69 0.05 0.57% |
Cross Country vs Charming Medical Correlation
Excellent diversification
The correlation between Cross Country Healthcare and MCTA is -0.6 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cross Country Healthcare and MCTA in the same portfolio, assuming nothing else is changed.
Moving together with Cross Stock
Moving against Cross Stock
| 0.84 | NPTH | NeuPath Health | PairCorr |
| 0.72 | DR | Medical Facilities | PairCorr |
| 0.68 | EHAB | Enhabit | PairCorr |
| 0.49 | AHX | Apiam Animal Health | PairCorr |
| 0.35 | AGL | agilon health | PairCorr |
Cross Country Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Cross Country and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Cross and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Cross Country Healthcare does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Cross Stock performing well and Cross Country Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cross Country's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TOI | 4.26 | (0.81) | 0.00 | (0.35) | 0.00 | 6.53 | 42.16 | |||
| EHAB | 1.67 | 0.43 | 0.20 | 1.15 | 1.54 | 4.81 | 11.79 | |||
| AUNA | 2.21 | (0.28) | 0.00 | (0.23) | 0.00 | 4.95 | 23.30 | |||
| SRDX | 1.90 | 0.40 | 0.22 | 0.43 | 1.26 | 2.09 | 49.69 | |||
| AGL | 4.80 | (0.42) | 0.00 | (0.05) | 0.00 | 10.00 | 30.19 | |||
| KIDS | 1.85 | (0.04) | (0.02) | 0.04 | 2.12 | 3.72 | 16.89 | |||
| TMCI | 3.59 | (1.61) | 0.00 | (0.68) | 0.00 | 6.51 | 28.25 | |||
| SNDA | 1.49 | 0.41 | 0.31 | 0.70 | 0.76 | 5.62 | 17.41 | |||
| OPRX | 2.89 | (0.95) | 0.00 | (0.42) | 0.00 | 6.04 | 19.39 | |||
| MCTA | 1.18 | 0.38 | 0.00 | 0.53 | 0.00 | 2.63 | 24.43 |
Cross Equities Net Income Analysis
Compare Cross Country Healthcare and related stocks such as Oncology Institute, Enhabit, and Auna SA Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOI | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | (4 M) | (14.3 M) | (10.9 M) | 152 K | (83.1 M) | (64.7 M) | (58.2 M) | (55.3 M) |
| EHAB | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 75 M | 111.1 M | (40.4 M) | (80.5 M) | (156.2 M) | (140.6 M) | (133.6 M) |
| AUNA | 22 M | 22 M | 22 M | 22 M | 22 M | 22 M | 22 M | 22 M | 37 M | 72.8 M | (7.3 M) | (27.1 M) | (85.2 M) | (252 M) | 110.7 M | 99.6 M | 104.6 M |
| AGL | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (60.1 M) | (406.5 M) | (106.6 M) | (262.6 M) | (260.2 M) | (234.1 M) | (245.8 M) |
| KIDS | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (7.9 M) | (6.6 M) | (8.9 M) | (12 M) | (13.7 M) | (32.9 M) | (16.3 M) | 1.3 M | (21 M) | (37.8 M) | (34 M) | (32.3 M) |
| TMCI | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (3.7 M) | (20.6 M) | (42.8 M) | (49.5 M) | (55.7 M) | (50.2 M) | (47.7 M) |
| SNDA | 3.7 M | 3 M | (3.1 M) | (16.5 M) | (24.1 M) | (14.3 M) | (28 M) | (44.2 M) | (53.6 M) | (36 M) | (295.4 M) | 125.6 M | (54.4 M) | (21.1 M) | (2.1 M) | (1.9 M) | (1.9 M) |
| OPRX | (361.5 K) | (2.1 M) | (364 K) | 215.8 K | (1 M) | (595.1 K) | (1.5 M) | (2.1 M) | 226.3 K | (3.1 M) | (2.2 M) | 378.1 K | (11.4 M) | (17.6 M) | (20.1 M) | (18.1 M) | (17.2 M) |
| MCTA | (305.1 K) | (305.1 K) | (305.1 K) | (305.1 K) | (305.1 K) | (305.1 K) | (305.1 K) | (305.1 K) | (305.1 K) | (305.1 K) | (305.1 K) | (305.1 K) | (305.1 K) | 777.8 K | 1.2 M | 1.4 M | 1.4 M |
Cross Country Healthcare and related stocks such as Oncology Institute, Enhabit, and Auna SA Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Cross Country Healthcare financial statement analysis. It represents the amount of money remaining after all of Cross Country Healthcare operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Cross Country Competitive Analysis
The better you understand Cross Country competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Cross Country's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Cross Country's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Cross Country Competition Performance Charts
Five steps to successful analysis of Cross Country Competition
Cross Country's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Cross Country Healthcare in relation to its competition. Cross Country's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Cross Country in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Cross Country's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Cross Country Healthcare, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Cross Country position
In addition to having Cross Country in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Software Thematic Idea Now
Software
Companies that develop and distribute software and software systems to individuals or business. The Software theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Software Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Cross Country Correlation with its peers. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Will Health Care Providers & Services sector continue expanding? Could Cross diversify its offerings? Factors like these will boost the valuation of Cross Country. Projected growth potential of Cross fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cross Country data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.79) | Earnings Share (0.49) | Revenue Per Share | Quarterly Revenue Growth (0.21) | Return On Assets |
Understanding Cross Country Healthcare requires distinguishing between market price and book value, where the latter reflects Cross's accounting equity. The concept of intrinsic value - what Cross Country's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Cross Country's price substantially above or below its fundamental value.
It's important to distinguish between Cross Country's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cross Country should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cross Country's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.